argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
835.99
-2.50 (-0.30%)
May 29, 2026, 4:00 PM EDT - Market closed
argenx SE Market Cap
argenx SE has a market cap or net worth of $51.98 billion as of May 29, 2026. Its market cap has increased by 60.71% in one year.
Market Cap
51.98B
Enterprise Value
47.53B
1-Year Change
60.71%
Ranking
Category
Stock Price
$835.99
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $51.98B, an increase of 8,310.30%. That is a compound annual growth rate of 63.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 51.73B | 0.79% |
| Dec 31, 2025 | 51.33B | 39.57% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vertex Pharmaceuticals | 113.59B |
| Regeneron Pharmaceuticals | 62.55B |
| Alnylam Pharmaceuticals | 40.32B |
| Revolution Medicines | 33.48B |
| Royalty Pharma | 32.11B |
| BeOne Medicines AG | 32.01B |
| BioNTech SE | 24.26B |
| Insmed | 23.17B |